You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 December 2012
Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2 MDS and AML Study in an Oral Presentation at ASH
4 December 2012
Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda
20 November 2012
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2 MDS and AML Study at ASH
31 October 2012
Astex Pharmaceuticals to Present at EORTC-NCI-AACR